Protagonist Therapeutics Inc (PTGX)
46.76
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
46.80
+0.04
(+0.09%)
After-Hours: 20:00
Protagonist Therapeutics Price to Book Value: 5.088 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 5.088 |
| October 31, 2024 | 4.988 |
| October 30, 2024 | 5.182 |
| October 29, 2024 | 5.270 |
| October 28, 2024 | 5.245 |
| October 25, 2024 | 5.143 |
| October 24, 2024 | 5.109 |
| October 23, 2024 | 5.070 |
| October 22, 2024 | 5.053 |
| October 21, 2024 | 5.001 |
| October 18, 2024 | 5.111 |
| October 17, 2024 | 5.116 |
| October 16, 2024 | 5.113 |
| October 15, 2024 | 5.184 |
| October 14, 2024 | 5.044 |
| October 11, 2024 | 4.905 |
| October 10, 2024 | 4.743 |
| October 09, 2024 | 4.808 |
| October 08, 2024 | 4.784 |
| October 07, 2024 | 4.766 |
| October 04, 2024 | 4.828 |
| October 03, 2024 | 4.825 |
| October 02, 2024 | 4.894 |
| October 01, 2024 | 4.828 |
| September 30, 2024 | 4.897 |
| Date | Value |
|---|---|
| September 27, 2024 | 4.849 |
| September 26, 2024 | 4.889 |
| September 25, 2024 | 5.021 |
| September 24, 2024 | 5.069 |
| September 23, 2024 | 5.022 |
| September 20, 2024 | 5.150 |
| September 19, 2024 | 4.997 |
| September 18, 2024 | 4.872 |
| September 17, 2024 | 4.887 |
| September 16, 2024 | 5.027 |
| September 13, 2024 | 5.116 |
| September 12, 2024 | 4.967 |
| September 11, 2024 | 4.874 |
| September 10, 2024 | 4.888 |
| September 09, 2024 | 4.852 |
| September 06, 2024 | 4.516 |
| September 05, 2024 | 4.572 |
| September 04, 2024 | 4.548 |
| September 03, 2024 | 4.506 |
| August 30, 2024 | 4.667 |
| August 29, 2024 | 4.602 |
| August 28, 2024 | 4.652 |
| August 27, 2024 | 4.599 |
| August 26, 2024 | 4.527 |
| August 23, 2024 | 4.535 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.138
Minimum
Jun 13 2022
11.04
Maximum
Jun 25 2020
4.064
Average
3.962
Median
Aug 28 2023
Price to Book Value Benchmarks
| Johnson & Johnson | 5.430 |
| Assembly Biosciences Inc | 2.982 |
| Precision BioSciences Inc | 0.8007 |
| Entrada Therapeutics Inc | 1.535 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 17.85 |
| Price to Free Cash Flow | 12.38 |
| Price | 46.76 |
| Earnings Yield | 5.60% |
| Market Cap | 2.754B |
| Operating PE Ratio | 18.78 |
| Normalized PE Ratio | 17.85 |